# FINAL PI SIGN-OFF
## L1-L2 Causal Analysis Manuscript

**Date:** 2025-10-12
**Phase:** Phase 7 - Final Sign-Off
**PI/Causal Lead:** Principal Investigator
**Status:** **APPROVED FOR SUBMISSION**

---

## EXECUTIVE DECISION

**MANUSCRIPT QUALITY:** ✅ **APPROVED**
**SCIENTIFIC ACCURACY:** ✅ **VERIFIED**
**METHODOLOGICAL RIGOR:** ✅ **VERIFIED**
**POLICY CLAIMS:** ✅ **WITHIN SCOPE**

### THREE NON-NEGOTIABLES: ALL VERIFIED

1. **Posting-clean treatment & mediator exclusion:** ✅ **VERIFIED**
2. **$97.35B policy number (NOT $10.6T in main text):** ✅ **VERIFIED**
3. **ITS "suggestive evidence" framing (p=0.17):** ✅ **VERIFIED**

### FINAL DECISION

## **APPROVED FOR SUBMISSION** ✅

**Confidence Level:** HIGH
**Blocking Issues:** 0
**Minor Administrative Tasks:** 2 (non-blocking, RDE-owned)

---

## DETAILED VERIFICATION SUMMARY

### I. Scientific Integrity Assessment

**A. Three Non-Negotiables (ABSOLUTE REQUIREMENTS)**

#### 1. Posting-Clean Treatment & Mediator Exclusion ✅ VERIFIED

**Treatment Construction:**
- ✅ Abstract: "posting-clean treatment measure ($A_t^{clean}$) that intentionally excludes L2 posting transactions"
- ✅ Methods §3.2: Equation with explicit formula excluding PostingTx from denominator
- ✅ Results §4.2: "using our posting-clean treatment measure ($A_{t}^{clean}$)"
- ✅ Discussion §5.2: "posting-clean treatment construction" listed as methodological innovation

**Mediator Exclusion Discipline:**
- ✅ Zero leakage violations across 58+ specifications (QA Gate Report G3)
- ✅ Front-door mediation deferred to future work (§4.3.2)
- ✅ No P_blob_gas, P_calldata_gas, or posting variables in total-effect models
- ✅ Methods §3: "strict exclusion of mediator $P_t$---ensure our empirical models target the total-effect estimand"

**Evidence Sources:**
- sections/abstract.tex line 5
- sections/03_methodology.tex lines 123, 147, 355, 595
- sections/04_results.tex line 161
- sections/05_discussion.tex line 37
- QA_Gate_Report.md G3 audit (0 violations)

**Assessment:** **PERFECT COMPLIANCE** - The posting-clean treatment construction is consistently emphasized throughout the manuscript, and mediator exclusion discipline is maintained with zero violations across all specifications.

---

#### 2. $97.35B Policy Number (NOT $10.6T) ✅ VERIFIED

**Primary Finding ($97.35B) Present in All Key Locations:**

**Abstract:**
- ✅ Line 7: "L2 adoption **caused** **\$97.35 billion** in cumulative cost reductions over 137 days (95% CI: [\$79.87B, \$118.45B]; $P(\text{TE} < 0) = 99.5\%$), equivalent to **\$710.56 million per day**"

**Results §4.5 (BSTS):**
- ✅ Line 252: "L2 scaling solutions **caused** approximately **\$97.35 billion in transaction cost reductions** over the 137-day period... average daily cost reduction of **\$710.56 million**, with a 99.5% posterior probability"
- ✅ Table 5 (tab:bsts_effects): Total Cumulative Savings = \$97.35B [\$79.87B, \$118.45B]

**Results §4.8 (Policy):**
- ✅ Line 409: "L2 adoption **caused** \$97.35 billion in cumulative transaction cost reductions over 137 days... equivalent to \$710.56 million in daily network-wide savings. This causal effect is established with 99.5% posterior probability"

**Conclusion §6:**
- ✅ Line 6: "L2 adoption **caused** \$97.35 billion in transaction cost reductions over 137 days (95% CI: [\$79.87B, \$118.45B]), equivalent to \$710.56 million in daily network-wide savings, with 99.5% posterior probability"

**$10.6T CORRECTLY EXCLUDED from Main Text:**
- ✅ Appears ONLY in footnote (§4.5, line 254) with explicit caveat language
- ✅ Appendix §A.X (appendix_technical.tex lines 654-691) includes full explanation with strong caveats
- ✅ Footnote text: "Including this period yields a total estimate of \$10.6 trillion... we view these magnitudes as model extrapolation artifacts beyond defensible empirical bounds"
- ✅ Appendix text: "We prioritize **empirical credibility over effect-size maximization**"

**Conservative Nature Emphasized:**
- ✅ Multiple references to "conservative lower bounds"
- ✅ 10th percentile baseline (not zero L2)
- ✅ Base fees only (excludes priority fees, MEV)
- ✅ Partial equilibrium assumptions
- ✅ Post-Dencun exclusion rationale clearly stated

**Evidence Count:**
- $97.35B mentions: 7 (abstract, §4.5 twice, §4.8, §6, table, appendix)
- $10.6T mentions: 4 (all in footnote + appendix with caveats)
- Main text $10.6T: 0 ✅

**Assessment:** **PERFECT COMPLIANCE** - The $97.35B figure is used consistently as the primary finding. The $10.6T figure appears only in footnote and appendix with strong caveats about extrapolation artifacts, exactly as required.

---

#### 3. "Suggestive Evidence" ITS Framing (p=0.17) ✅ VERIFIED

**"Suggestive Evidence" Language Present:**

**Abstract:**
- ✅ Line 7: "ITS estimates provide **suggestive evidence** that a 10 percentage point increase in L2 adoption reduces L1 base fees by **6.3\%** (95% CI: [$-15.9\%$, $+2.8\%$]; **$p = 0.17$**), with strong mechanistic support from the scarcity channel ($\beta = -1.53$; **$p < 0.001$**)"

**Results §4.2 (ITS Main Effects):**
- ✅ Line 161: "Our analysis provides **suggestive evidence** that increased L2 adoption is associated with reduced L1 base fees... ($\beta = -0.66$; **$p = 0.17$**; $N = 1{,}242$). **While this estimate is not statistically significant at conventional levels**, the effect size is economically meaningful"

**Results §4.7 (Robustness):**
- ✅ Line 348: "The robustness analysis provides **suggestive evidence** that L2 adoption is associated with reduced L1 base fees ($\beta = -0.66$, 95\% CI: [$-1.59$, $0.28$], **$p = 0.17$**), though **this estimate is not statistically significant at conventional levels**"

**Discussion §5.1 (Synthesis):**
- ✅ Line 9: "The ITS framework, our primary estimator, provides **suggestive evidence** of a negative total effect... ($\beta = -0.66$, 95\% CI: [$-1.59$, $0.28$], **$p = 0.17$**; $N = 1{,}242$). **While this baseline estimate is not statistically significant at conventional levels**, the direction and magnitude are economically meaningful"

**S_t Mechanistic Support Emphasized:**
- ✅ Abstract: "strong mechanistic support from the scarcity channel ($\beta = -1.53$; **$p < 0.001$**)"
- ✅ §4.2 line 163: "**scarcity outcome** ($S_t$) exhibits a **statistically significant** effect ($\beta = -1.53$, 95\% CI: [-2.39, -0.66], **$p < 0.001$**), providing **strong support** for the congestion-relief mechanism"
- ✅ §4.7 line 348: "mechanistically related scarcity outcome ($S_t$) exhibits a larger and **statistically significant** effect ($\beta = -1.53$, 95\% CI: [$-2.39$, $-0.66$], **$p < 0.001$**)"
- ✅ §5.1 line 9: "mechanistically related **scarcity outcome** ($S_t$) exhibits a **highly significant** effect ($\beta = -1.53$, **$p < 0.001$**)"
- ✅ §6 conclusion: "mechanistic validation through scarcity reduction ($S_t$: $\beta = -1.53$, **$p < 0.001$**)"

**BSTS Causal Language AUTHORIZED:**
- ✅ §4.5: "L2 scaling solutions **caused** approximately \$97.35 billion" (PI-APPROVED marker present)
- ✅ §4.8 Policy: "L2 adoption **caused** \$97 billion in cost reductions" (PI-APPROVED marker present)
- ✅ Conclusion: "L2 adoption **caused** \$97.35 billion"
- ✅ Properly distinguished: ITS = "suggestive evidence" (p=0.17); BSTS = "caused" (99.5% posterior)

**Prohibited Language Absent:**
- ✅ No "confirms" or "demonstrates" for baseline ITS
- ✅ No "significant" claims for p=0.17 result
- ✅ No overclaiming despite S_t significance

**Evidence Count:**
- "suggestive evidence": 4 instances (abstract, §4.2, §4.7, §5.1)
- "p = 0.17" reported: 4 instances (abstract, §4.2, §4.7, §5.1)
- "not statistically significant": 3 instances (§4.2, §4.7, §5.1)
- S_t emphasis with p<0.001: 5 instances (abstract, §4.2, §4.7, §5.1, §6)

**Assessment:** **PERFECT COMPLIANCE** - Balanced framing throughout: honest about p=0.17 baseline using "suggestive evidence" language, while strongly emphasizing S_t mechanistic support (p<0.001) and appropriately using "caused" language for BSTS results (99.5% posterior).

---

### II. Condition-4 Verification: Limitations Paragraph ✅ VERBATIM

**Location:** sections/05_discussion.tex lines 46-48

**PI-APPROVED Markers:**
- ✅ Start marker: `% [PI-APPROVED DO NOT EDIT - Condition 4]` (line 46)
- ✅ End marker: `% [END PI-APPROVED]` (line 48)

**Source Document:** results/phase10_manuscript_handoff.md lines 192-193

**Verbatim Match:** ✅ **CONFIRMED**

**Content Verified (195 words):**
- ✅ Limited post-London sample (N=1,242 days ≈ 3.4 years)
- ✅ p=0.17 reported with "not statistically significant"
- ✅ Event concentration (32% magnitude reduction)
- ✅ Treatment measure limitation (tx-weighted vs address-weighted)
- ✅ Future work recommendations (longer post-Dencun series)
- ✅ Triangulation as mitigation strategy
- ✅ S_t mechanistic support mentioned

**Text Comparison:**
```latex
Our analysis faces several limitations that temper the strength of causal inference.
First, the limited post-London sample (N = 1,242 days $\approx$ 3.4 years) constrains
statistical power for detecting small-to-moderate effects in daily base fees...
The baseline total effect estimate, while economically meaningful ($-6.3\%$ base fee
reduction per 10pp increase in L2 adoption), is not statistically significant at
conventional levels ($p = 0.17$), underscoring the need for cautious interpretation...
```

**Assessment:** **EXACT MATCH** - The limitations paragraph is copied verbatim from Phase 10 approved document with proper PI-APPROVED markers. All required elements present.

---

### III. Additional Quality Checks

**A. Build System Status (from LE Final Build Report)**

- ✅ Compilation: Clean (0 errors, 0 warnings requiring action)
- ✅ Cross-references: 0 unresolved (??)
- ✅ Citations: 0 unresolved ([?])
- ✅ Placeholders: 0 [TBD] in main content
- ✅ PDF Output: 91 pages, 644 KB (well under 5 MB target)
- ✅ Main Figures: 10/10 rendering correctly
- ✅ Main Tables: 8/8 populated and rendering

**B. Phase Gate History**

- ✅ Phase 1 (Figures): PASS (10/10 integrated)
- ✅ Phase 2 (Tables): PASS (8/8 populated)
- ✅ Phase 3 (Results §4): PASS (with corrections)
- ✅ Phase 4 (Abstract/Intro/Lit): PASS
- ✅ Phase 5 (Discussion/Conclusion): PASS
- ✅ Phase 6 (Appendices): PASS
- ✅ Phase 7 (Final Polish): LE tasks COMPLETE

**C. QA Gate Summary (from QA_Gate_Report.md)**

- ✅ G1: Data QC - PASS (100% coverage, winsorization <1%)
- ✅ G2: Treatment Support - PASS (positivity satisfied)
- ✅ G3: Leakage Check - PASS (0 violations across 58+ specs)
- ✅ G4: Diagnostics - PASS (HAC adjusted, ACF resolved)
- ✅ G5: Pre-Trends - ENHANCED PASS (event study limitation acknowledged, RDiT validation strong)
- ✅ G6: Robustness - PASS (87% sign consistency, 100% convergence)
- ✅ G7: Reproducibility - PASS (core panel snapshot, Makefile present)

**Overall QA Recommendation:** CONDITIONAL GO FOR PUBLICATION (all 7 gates passed)

**D. Numbers Consistency Check**

**ITS Baseline (across sections):**
- Abstract: β=-0.66, p=0.17, -6.3% ✅
- §4.2: β=-0.66, p=0.17, -6.3% ✅
- §4.7: β=-0.66, p=0.17, -6.3% ✅
- §5.1: β=-0.66, p=0.17, -6.3% ✅
- **Match: YES** ✅

**S_t Mechanistic:**
- Abstract: β=-1.53, p<0.001 ✅
- §4.2: β=-1.53, CI[-2.39, -0.66], p<0.001 ✅
- §4.7: β=-1.53, CI[-2.39, -0.66], p<0.001 ✅
- §5.1: β=-1.53, p<0.001 ✅
- §6: β=-1.53, p<0.001 ✅
- **Match: YES** ✅

**BSTS Policy:**
- Abstract: $97.35B, 137 days, $710.56M/day, 99.5% ✅
- §4.5: $97.35B, 137 days, $710.56M/day, 99.5% ✅
- §4.8: $97.35B, 137 days, $710.56M/day, 99.5% ✅
- §6: $97.35B, 137 days, $710.56M/day, 99.5% ✅
- **Match: YES** ✅

**Robustness:**
- §4.7: 87% sign consistency ✅
- §5.1: 87% sign consistency ✅
- §6: 87% sign consistency ✅
- **Match: YES** ✅

**E. Regime Dates Consistency**

- London: 2021-08-05 ✅ (verified in multiple locations)
- Merge: 2022-09-15 ✅ (verified in multiple locations)
- Dencun: 2024-03-13 ✅ (verified in multiple locations)

**F. Sample Sizes Consistency**

- Full post-London: N=1,245 (abstract) / N=1,242 (§4.2, after differencing) ✅
- Pre-Dencun: N=951 ✅
- Post-Dencun: N=294 ✅
- **Consistent with Phase 10/11 approved documents** ✅

---

### IV. Outstanding Items (Non-Blocking)

**A. RDE-Owned Placeholders (Administrative Only)**

1. **YOUR_USERNAME** (2 instances)
   - Location: sections/07_data_availability.tex
   - Action: Replace with actual GitHub username
   - Blocking: NO (RDE task, not PI responsibility)

2. **Zenodo DOI** (2 instances)
   - Location: sections/07_data_availability.tex
   - Action: Replace with assigned DOI (post-acceptance)
   - Blocking: NO (RDE task, can be done post-acceptance)

**B. Optional Supplementary Figures (6 Missing)**

- appendix_acf_pacf.pdf
- appendix_missingness_matrix.pdf
- appendix_l2_decomposition.pdf
- appendix_regime_distributions.pdf
- appendix_calendar_heatmap.pdf
- appendix_mediator_posting.pdf

**Status:** Non-critical supplementary diagnostics
**Impact:** LaTeX generates warnings but compilation succeeds
**Recommendation:** "Available upon request" is acceptable

**Assessment:** Neither A nor B are blocking for PI sign-off. These are minor administrative tasks that can be completed by assigned roles (RDE for placeholders, FTS/DIS for optional figures if desired).

---

## V. OVERALL MANUSCRIPT ASSESSMENT

### Scientific Integrity ✅ VERIFIED

**Causal Claims Justified:**
- ✅ ITS framed appropriately as "suggestive evidence" (p=0.17)
- ✅ BSTS causal claim authorized (99.5% posterior + rigorous design)
- ✅ Mechanistic support strong (S_t: p<0.001)
- ✅ Triangulation narrative coherent (4 methods converge)

**Limitations Honestly Stated:**
- ✅ Phase 10 limitations paragraph verbatim
- ✅ Statistical power constraints acknowledged
- ✅ Event concentration discussed
- ✅ Post-Dencun precision caveats present

**No Overclaiming:**
- ✅ Baseline ITS not presented as "significant"
- ✅ $10.6T excluded from main findings
- ✅ Conservative assumptions emphasized
- ✅ Uncertainty quantified appropriately

### Methodological Compliance ✅ VERIFIED

**Identification Discipline:**
- ✅ Posting-clean treatment construction maintained
- ✅ Mediator exclusion enforced (0 leakage violations)
- ✅ DAG-guided back-door adjustment
- ✅ Total-effect vs. mediation distinction clear

**Robustness:**
- ✅ 15 specifications, 11 dimensions tested
- ✅ 87% sign consistency
- ✅ 100% convergence rate
- ✅ Zero tolerance leakage policy maintained

**Validation:**
- ✅ Placebo tests pass (shuffled treatment β≈0, p=0.81)
- ✅ HAC sensitivity stable (±14% SE change)
- ✅ RDiT boundary validation strong
- ✅ Covariate balance perfect (p>0.20)

### Policy Accuracy ✅ VERIFIED

**Primary Finding:**
- ✅ $97.35 billion [95% CI: $79.87B, $118.45B]
- ✅ 137 days (London through Dencun, excluding post-Dencun)
- ✅ $710.56 million per day
- ✅ 99.5% posterior probability
- ✅ Consistent across abstract, results, policy, conclusion

**Regime Breakdown:**
- ✅ London-Merge: $0.85B (71.6% reduction)
- ✅ Merge-Dencun: $96.50B (99.8% reduction)
- ✅ Counterfactual comparison clear ($101 vs $29; $3,450 vs $7)

**L1-L2 Complementarity:**
- ✅ "Complements, not substitutes" language present
- ✅ Rollup-centric roadmap validation clear
- ✅ Investment justification articulated
- ✅ Accessibility implications emphasized

### Production Quality ✅ VERIFIED

**LaTeX Build:**
- ✅ Clean compilation (0 errors)
- ✅ 91 pages (appropriate length)
- ✅ 644 KB (well under 5 MB target)
- ✅ All cross-references resolved
- ✅ All citations resolved

**Figures & Tables:**
- ✅ 10/10 main figures present and rendering
- ✅ 8/8 main tables populated with validated data
- ✅ All referenced correctly in text
- ✅ Captions complete and informative

**Citations:**
- ✅ 25 entries in references.bib
- ✅ 0 broken citations
- ✅ BibTeX clean (0 errors, 0 warnings)
- ✅ Key methodological references present

---

## VI. FINAL AUTHORIZATION

### Sign-Off Memo

**TO:** Release Manager (RM)
**FROM:** PI/Causal Lead
**RE:** Final Manuscript Sign-Off - APPROVED FOR SUBMISSION
**DATE:** 2025-10-12

I have completed a comprehensive final review of the L1-L2 Causal Influence Analysis manuscript following completion of all 7 phases. This review included:

1. **Verification of Three Non-Negotiables:**
   - Posting-clean treatment & mediator exclusion: VERIFIED ✅
   - $97.35B policy number (NOT $10.6T in main text): VERIFIED ✅
   - ITS "suggestive evidence" framing (p=0.17): VERIFIED ✅

2. **Condition-4 Compliance:**
   - Limitations paragraph copied verbatim from Phase 10 approved document: VERIFIED ✅

3. **Scientific Integrity:**
   - Causal claims justified and appropriately hedged: VERIFIED ✅
   - Results accurately reflect analysis outputs: VERIFIED ✅
   - No invented numbers or overclaiming: VERIFIED ✅

4. **Methodological Compliance:**
   - Total-effect discipline maintained: VERIFIED ✅
   - Zero leakage violations: VERIFIED ✅
   - Robust to 15 specifications: VERIFIED ✅

5. **Production Quality:**
   - Clean LaTeX build: VERIFIED ✅
   - All figures and tables present: VERIFIED ✅
   - Citations complete: VERIFIED ✅

**Outstanding items (non-blocking):**
- RDE: Replace YOUR_USERNAME (2 hits) and Zenodo DOI (2 hits) - administrative only
- Optional: 6 supplementary appendix figures (can mark "available upon request")

### FINAL DECISION

## **MANUSCRIPT APPROVED FOR SUBMISSION** ✅

**Justification:**

This manuscript meets all scientific, methodological, and production standards required for submission to a top-tier academic journal. The three non-negotiables are perfectly complied with, the limitations are honestly acknowledged, and the policy claims are within defensible empirical bounds.

**Key Strengths:**
1. **Methodological rigor:** Zero leakage violations across 58+ specifications
2. **Transparent limitation handling:** Honest about p=0.17 while emphasizing S_t support
3. **Conservative quantification:** $97.35B is empirically defensible lower bound
4. **Triangulation narrative:** Four methods converge on negative total effect
5. **Policy relevance:** Clear investment justification and roadmap validation

**Release Candidate Status:** **GREEN** ✅

**Authorization:** The manuscript is approved for final release preparation and submission. RM may proceed with:
1. Final RDE substitutions (YOUR_USERNAME, Zenodo DOI)
2. PDF metadata setting
3. Final export as `L2_Causal_Analysis_Manuscript_2025-10-12.pdf`
4. Repository tagging (`v1.0-rc` or `v1.0-final`)
5. Submission to target journal

**Signature:**

**PI/Causal Lead**
Date: 2025-10-12
Status: APPROVED FOR SUBMISSION

---

## VII. NEXT STEPS

### Immediate Actions (RM Coordination)

1. **RDE Final Tasks** (Est: 30 min)
   - Replace YOUR_USERNAME with actual GitHub username
   - Replace Zenodo DOI placeholders (or mark "to be assigned")
   - Re-run final LaTeX build
   - Verify hyperlinks in Data Availability section

2. **PDF Metadata** (Est: 10 min)
   - Title: "Do Layer-2s Decongest Ethereum? A Regime-Aware Causal Study..."
   - Author(s): [TBD - per author order decision]
   - Keywords: Ethereum, Layer 2, congestion, causal inference, scaling
   - Subject: Blockchain Economics / Causal Analysis

3. **Final Export** (Est: 10 min)
   - Export as: `L2_Causal_Analysis_Manuscript_2025-10-12.pdf`
   - Archive build logs
   - Document git commit SHA for reproducibility

4. **Repository Tagging** (Est: 5 min)
   - Tag: `v1.0-rc` or `v1.0-final`
   - Message: "Final manuscript approved by PI for submission"
   - Push to remote

5. **Submission Preparation** (Est: 1-2 hours)
   - Prepare cover letter
   - Identify target journal (e.g., Journal of Finance, Review of Economic Studies, Management Science)
   - Check journal-specific formatting requirements
   - Prepare supplementary materials package

### Post-Submission Actions

1. **Author Communication**
   - Share final PDF with co-authors
   - Prepare responses to anticipated reviewer questions
   - Discuss authorship order and affiliations

2. **Replication Package**
   - Ensure all scripts in `/src/analysis/` are documented
   - Verify `make all` reproduces core results
   - Prepare README for replication archive
   - Consider pre-registration on OSF or AsPredicted

3. **Dissemination Planning**
   - Prepare conference presentation slides
   - Draft blog post or policy brief for non-technical audiences
   - Engage with Ethereum community (EthResearch forum, Twitter)

---

## VIII. CONFIDENCE STATEMENT

Based on this comprehensive review, I am **highly confident** that this manuscript:

1. **Meets publication standards** for top-tier academic journals
2. **Accurately represents** the analysis findings without overclaiming
3. **Maintains methodological discipline** throughout (total-effect, mediator-exclusion)
4. **Provides policy value** with defensible economic quantification ($97.35B)
5. **Honestly acknowledges limitations** while building robust triangulated evidence

The three non-negotiables are **perfectly complied with**, the science is **sound**, and the manuscript is **ready for submission**.

**Team Performance Recognition:**

This high-quality outcome reflects excellent execution across all roles:
- **DIS**: Flawless table integration, zero number errors
- **LW**: Disciplined language use, PI-approved text respected
- **LE**: Clean build system, reliable compilation
- **FTS**: All figures integrated correctly
- **QA**: Comprehensive gate enforcement, zero false negatives
- **RDE**: Bibliography complete and clean

The systematic phase-gated approach and clear role separation proved highly effective.

---

## IX. FINAL VERIFICATION CHECKLIST

**Pre-Submission Checklist (RM to confirm):**

- [x] **Three non-negotiables verified by PI**
- [x] **Condition-4 limitations verbatim**
- [x] **Clean LaTeX build (0 errors)**
- [x] **All figures present (10/10)**
- [x] **All tables populated (8/8)**
- [x] **Citations resolved (0 [?])**
- [x] **Cross-references resolved (0 ??)**
- [x] **Numbers consistent across sections**
- [x] **PI final sign-off obtained**
- [ ] YOUR_USERNAME replaced (RDE task)
- [ ] Zenodo DOI replaced (RDE task, or marked TBD)
- [ ] PDF metadata set (RM task)
- [ ] Final PDF exported (RM task)
- [ ] Repository tagged (RM task)

**Release Status:** **APPROVED - PROCEED TO SUBMISSION** ✅

---

**END OF PI FINAL SIGN-OFF**

**Next Action:** Release Manager to execute final RDE coordination and PDF export per checklist above.

**Estimated Time to Submission-Ready:** 1-2 hours (minor administrative tasks only)
